» Articles » PMID: 39503257

Myh9b is a Critical Non-muscle Myosin II Encoding Gene That Interacts with Myh9a and Myh10 During Zebrafish Development in Both Compensatory and Redundant Pathways

Overview
Journal G3 (Bethesda)
Date 2024 Nov 6
PMID 39503257
Authors
Affiliations
Soon will be listed here.
Abstract

Non-muscle myosin (NMII) motor proteins have diverse developmental functions due to their roles in cell shape changes, cell migration, and cell adhesion. Zebrafish are an ideal vertebrate model system to study the NMII encoding myh genes and proteins due to high sequence homology, established gene editing tools, and rapid ex utero development. In humans, mutations in the NMII encoding MYH genes can lead to abnormal developmental processes and disease. This study utilized zebrafish myh9a, myh9b, and myh10 null mutants to examine potential genetic interactions and roles for each gene in development. It was determined that the myh9b gene is the most critical NMII encoding gene, as myh9b mutants develop pericardial edema and have a partially penetrant lethal phenotype, which was not observed in the other myh mutants. This study also established that genetic interactions occur between the zebrafish myh9a, myh9b, and myh10 genes where myh9b is required for the expression of both myh9a and myh10, and myh10 is required for the expression of myh9b. Additionally, protein analyses suggested that enhanced NMII protein stability in some mutant backgrounds may play a role in compensation. Finally, double mutant studies revealed different and more severe phenotypes at earlier time points than single mutants, suggesting roles for tissue specific genetic redundancy, and in some genotypes, haploinsufficiency. These mutants are the first in vivo models allowing for the study of complete loss of the NMIIA and NMIIB proteins, establishing them as valuable tools to elucidate the role of NMII encoding myh genes in development and disease.

References
1.
Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C . Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet. 2000; 26(1):103-5. DOI: 10.1038/79063. View

2.
Kim B, Kim A, Han J, Lee C, Oh D, Choi B . Discovery of MYH14 as an important and unique deafness gene causing prelingually severe autosomal dominant nonsyndromic hearing loss. J Gene Med. 2017; 19(4). DOI: 10.1002/jgm.2950. View

3.
Franke J, Montague R, Rickoll W, Kiehart D . An MYH9 human disease model in flies: site-directed mutagenesis of the Drosophila non-muscle myosin II results in hypomorphic alleles with dominant character. Hum Mol Genet. 2007; 16(24):3160-73. DOI: 10.1093/hmg/ddm279. View

4.
Hunter G, He L, Perrimon N, Charras G, Giniger E, Baum B . A role for actomyosin contractility in Notch signaling. BMC Biol. 2019; 17(1):12. PMC: 6369551. DOI: 10.1186/s12915-019-0625-9. View

5.
Ma X, Adelstein R . A point mutation in Myh10 causes major defects in heart development and body wall closure. Circ Cardiovasc Genet. 2014; 7(3):257-65. PMC: 4106703. DOI: 10.1161/CIRCGENETICS.113.000455. View